• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

F1000Res . Epidemiology of first cases of SARS-CoV-2 infection, from March to April 2020, in Gabon

tetano

Editor, Senior Moderator
F1000Res


. 2022 Feb 17;11:205.
doi: 10.12688/f1000research.74378.2. eCollection 2022.
Epidemiology of first cases of SARS-CoV-2 infection, from March to April 2020, in Gabon


Sonia Etenna Lekana-Douki[SUP] 1 [/SUP], Nadine N'dilimabaka[SUP] 1 2 [/SUP], Elvire Mbongo-Kama[SUP] 3 [/SUP], Marisca Kandet Yattara[SUP] 4 [/SUP], Armel Mintsa Ndong[SUP] 5 [/SUP], Audrey Michel Ngonga Dikongo[SUP] 1 [/SUP], Julia Cyrielle Andeko[SUP] 1 [/SUP], Ornella Zong Minko[SUP] 1 [/SUP], Danielle Styvie Koumba Mavoungou[SUP] 1 [/SUP], Abdoulaye Diane[SUP] 1 [/SUP], Arsene Mabika Mabika[SUP] 1 [/SUP], Telstar Ndong Mebaley[SUP] 1 [/SUP], Nal Kennedy Ndjangangoye[SUP] 1 [/SUP], Octavie Banga Mve-Ella[SUP] 1 [/SUP], Linda Bohou Kombila[SUP] 1 [/SUP], Joa Braithe Mangombi Pambou[SUP] 1 [/SUP], Jeordy Dimitri Engone Ondo[SUP] 1 [/SUP], Gael Darren Maganga[SUP] 1 6 [/SUP], Jean-Bernard Lekana-Douki[SUP] 1 7 [/SUP]



Affiliations
Free PMC article

Abstract

Background After the first cases of coronaviruses disease 2019 (COVID-19) in China in January 2020, the epidemic spread around the world. Few data are available from Central Africa. We conducted a study to monitor this emerging disease in Gabon, a Central Africa country. Methods In order to set up an epidemiological surveillance of COVID-19 in Gabon, we led molecular investigations on nasopharyngeal and oropharyngeal samples from the 1161 first suspected cases of COVID-19. A Reverse Ttranscriptase Polymerase Chain Reaction (RT-PCR) was performed using primers and probes targeted the E gene and polymerase gene according to the kit Tib-Molbiol. Results We diagnosed the first case of COVID-19 on March, 12 2020. Among those suspected cases, 83 were confirmed cases. There was no significant difference in prevalence of SARS-CoV-2 between age groups (p = 0.14). Seventy-three percent were asymptomatic. The viral loads were significantly higher in the nasopharyngeal samples than in the oropharyngeal samples (p=0.03). There was no significant difference in viral loads between age groups (p=0.9895) and no correlation between clinical symptoms and viral loads (p=0.06042). Conclusion In conclusion, this study provides the first molecular data from Gabon concerning the COVID-19 pandemic. The data showed that most of the infected people were asymptomatic. The viral load was higher in the nasopharyngeal samples.

Keywords: COVID-19; Diagnostic; Epidemiology; Gabon; S gene; Viral load.
 
Back
Top Bottom